nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Epirubicin—thyroid cancer	0.22	1	CrCtD
Doxorubicin—Anthracyclines—Epirubicin—thyroid cancer	0.178	0.657	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Epirubicin—thyroid cancer	0.0929	0.343	CiPCiCtD
Doxorubicin—bone cancer—thyroid cancer	0.0629	0.408	CtDrD
Doxorubicin—Daunorubicin—Epirubicin—thyroid cancer	0.0467	0.333	CrCrCtD
Doxorubicin—Idarubicin—Epirubicin—thyroid cancer	0.0467	0.333	CrCrCtD
Doxorubicin—Valrubicin—Epirubicin—thyroid cancer	0.0467	0.333	CrCrCtD
Doxorubicin—kidney cancer—thyroid cancer	0.0465	0.301	CtDrD
Doxorubicin—lung cancer—thyroid cancer	0.0449	0.291	CtDrD
Doxorubicin—YWHAG—Epirubicin—thyroid cancer	0.0305	0.22	CbGbCtD
Doxorubicin—AURKA—Epirubicin—thyroid cancer	0.0305	0.22	CbGbCtD
Doxorubicin—DHCR7—Epirubicin—thyroid cancer	0.0305	0.22	CbGbCtD
Doxorubicin—RALBP1—Sorafenib—thyroid cancer	0.0212	0.153	CbGbCtD
Doxorubicin—TOP2A—Epirubicin—thyroid cancer	0.00619	0.0446	CbGbCtD
Doxorubicin—ABCC1—Vandetanib—thyroid cancer	0.00499	0.0359	CbGbCtD
Doxorubicin—ABCC1—Epirubicin—thyroid cancer	0.00343	0.0247	CbGbCtD
Doxorubicin—ABCG2—Vandetanib—thyroid cancer	0.00334	0.024	CbGbCtD
Doxorubicin—ABCC2—Sorafenib—thyroid cancer	0.00223	0.016	CbGbCtD
Doxorubicin—ABCG2—Sorafenib—thyroid cancer	0.00201	0.0145	CbGbCtD
Doxorubicin—CYP2B6—Sorafenib—thyroid cancer	0.00142	0.0102	CbGbCtD
Doxorubicin—ABCB1—Sorafenib—thyroid cancer	0.000726	0.00522	CbGbCtD
Doxorubicin—CYP3A4—Vandetanib—thyroid cancer	0.000721	0.00519	CbGbCtD
Doxorubicin—CYP2D6—Sorafenib—thyroid cancer	0.000684	0.00492	CbGbCtD
Doxorubicin—CBR3—saliva-secreting gland—thyroid cancer	0.00048	0.0344	CbGeAlD
Doxorubicin—CYP3A4—Sorafenib—thyroid cancer	0.000435	0.00313	CbGbCtD
Doxorubicin—AKR1A1—saliva-secreting gland—thyroid cancer	0.000371	0.0266	CbGeAlD
Doxorubicin—CBR3—trachea—thyroid cancer	0.00037	0.0265	CbGeAlD
Doxorubicin—ABCB8—thyroid gland—thyroid cancer	0.000304	0.0218	CbGeAlD
Doxorubicin—CBR3—thyroid gland—thyroid cancer	0.000293	0.021	CbGeAlD
Doxorubicin—AKR1A1—trachea—thyroid cancer	0.000286	0.0205	CbGeAlD
Doxorubicin—NDUFS2—saliva-secreting gland—thyroid cancer	0.000279	0.02	CbGeAlD
Doxorubicin—NDUFS3—saliva-secreting gland—thyroid cancer	0.000276	0.0198	CbGeAlD
Doxorubicin—NOS3—neck—thyroid cancer	0.000274	0.0196	CbGeAlD
Doxorubicin—ABCB8—head—thyroid cancer	0.00027	0.0193	CbGeAlD
Doxorubicin—DHCR7—saliva-secreting gland—thyroid cancer	0.000262	0.0188	CbGeAlD
Doxorubicin—CBR3—head—thyroid cancer	0.00026	0.0186	CbGeAlD
Doxorubicin—YWHAG—saliva-secreting gland—thyroid cancer	0.00024	0.0172	CbGeAlD
Doxorubicin—AKR1A1—thyroid gland—thyroid cancer	0.000226	0.0162	CbGeAlD
Doxorubicin—RALBP1—saliva-secreting gland—thyroid cancer	0.000217	0.0156	CbGeAlD
Doxorubicin—NDUFS2—trachea—thyroid cancer	0.000215	0.0154	CbGeAlD
Doxorubicin—NDUFS3—trachea—thyroid cancer	0.000213	0.0152	CbGeAlD
Doxorubicin—NQO1—neck—thyroid cancer	0.000208	0.0149	CbGeAlD
Doxorubicin—NDUFS7—thyroid gland—thyroid cancer	0.000206	0.0147	CbGeAlD
Doxorubicin—CBR1—saliva-secreting gland—thyroid cancer	0.000203	0.0145	CbGeAlD
Doxorubicin—DHCR7—trachea—thyroid cancer	0.000202	0.0145	CbGeAlD
Doxorubicin—AKR1A1—head—thyroid cancer	0.000201	0.0144	CbGeAlD
Doxorubicin—AURKA—thyroid gland—thyroid cancer	0.000191	0.0137	CbGeAlD
Doxorubicin—ABCB8—lymph node—thyroid cancer	0.000189	0.0135	CbGeAlD
Doxorubicin—YWHAG—trachea—thyroid cancer	0.000185	0.0133	CbGeAlD
Doxorubicin—POR—saliva-secreting gland—thyroid cancer	0.000183	0.0131	CbGeAlD
Doxorubicin—NDUFS7—head—thyroid cancer	0.000182	0.0131	CbGeAlD
Doxorubicin—CBR3—lymph node—thyroid cancer	0.000182	0.013	CbGeAlD
Doxorubicin—NOS1—thyroid gland—thyroid cancer	0.000171	0.0123	CbGeAlD
Doxorubicin—NDUFS2—thyroid gland—thyroid cancer	0.00017	0.0122	CbGeAlD
Doxorubicin—AURKA—head—thyroid cancer	0.00017	0.0121	CbGeAlD
Doxorubicin—NDUFS3—thyroid gland—thyroid cancer	0.000168	0.0121	CbGeAlD
Doxorubicin—RALBP1—trachea—thyroid cancer	0.000168	0.012	CbGeAlD
Doxorubicin—NOS3—trachea—thyroid cancer	0.000165	0.0118	CbGeAlD
Doxorubicin—NQO1—saliva-secreting gland—thyroid cancer	0.000162	0.0116	CbGeAlD
Doxorubicin—DHCR7—thyroid gland—thyroid cancer	0.00016	0.0115	CbGeAlD
Doxorubicin—CBR1—trachea—thyroid cancer	0.000156	0.0112	CbGeAlD
Doxorubicin—ABCC6—thyroid gland—thyroid cancer	0.000156	0.0112	CbGeAlD
Doxorubicin—AKR1C3—trachea—thyroid cancer	0.000154	0.0111	CbGeAlD
Doxorubicin—NOS1—head—thyroid cancer	0.000152	0.0109	CbGeAlD
Doxorubicin—NDUFS2—head—thyroid cancer	0.000151	0.0108	CbGeAlD
Doxorubicin—NDUFS3—head—thyroid cancer	0.000149	0.0107	CbGeAlD
Doxorubicin—YWHAG—thyroid gland—thyroid cancer	0.000147	0.0105	CbGeAlD
Doxorubicin—ABCC10—saliva-secreting gland—thyroid cancer	0.000145	0.0104	CbGeAlD
Doxorubicin—DHCR7—head—thyroid cancer	0.000142	0.0102	CbGeAlD
Doxorubicin—POR—trachea—thyroid cancer	0.000141	0.0101	CbGeAlD
Doxorubicin—AKR1A1—lymph node—thyroid cancer	0.000141	0.0101	CbGeAlD
Doxorubicin—ABCC6—head—thyroid cancer	0.000138	0.0099	CbGeAlD
Doxorubicin—RALBP1—thyroid gland—thyroid cancer	0.000133	0.00949	CbGeAlD
Doxorubicin—NOS3—thyroid gland—thyroid cancer	0.00013	0.00934	CbGeAlD
Doxorubicin—YWHAG—head—thyroid cancer	0.00013	0.00932	CbGeAlD
Doxorubicin—NDUFS7—lymph node—thyroid cancer	0.000128	0.00915	CbGeAlD
Doxorubicin—NQO1—trachea—thyroid cancer	0.000125	0.00897	CbGeAlD
Doxorubicin—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.000124	0.195	CbGdCrCtD
Doxorubicin—CBR1—thyroid gland—thyroid cancer	0.000124	0.00886	CbGeAlD
Doxorubicin—AKR1C3—thyroid gland—thyroid cancer	0.000122	0.00875	CbGeAlD
Doxorubicin—AURKA—lymph node—thyroid cancer	0.000119	0.0085	CbGeAlD
Doxorubicin—RALBP1—head—thyroid cancer	0.000118	0.00842	CbGeAlD
Doxorubicin—NOS3—head—thyroid cancer	0.000116	0.00828	CbGeAlD
Doxorubicin—ABCC10—trachea—thyroid cancer	0.000112	0.00801	CbGeAlD
Doxorubicin—POR—thyroid gland—thyroid cancer	0.000112	0.00799	CbGeAlD
Doxorubicin—CBR1—head—thyroid cancer	0.00011	0.00786	CbGeAlD
Doxorubicin—NDUFS2—lymph node—thyroid cancer	0.000106	0.00758	CbGeAlD
Doxorubicin—NDUFS3—lymph node—thyroid cancer	0.000105	0.00749	CbGeAlD
Doxorubicin—CBR3—Daunorubicin—Epirubicin—thyroid cancer	0.000104	0.164	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Epirubicin—thyroid cancer	0.000104	0.164	CbGdCrCtD
Doxorubicin—TOP2A—thyroid gland—thyroid cancer	0.000104	0.00745	CbGeAlD
Doxorubicin—DHCR7—lymph node—thyroid cancer	9.93e-05	0.00711	CbGeAlD
Doxorubicin—NQO1—thyroid gland—thyroid cancer	9.91e-05	0.0071	CbGeAlD
Doxorubicin—YWHAG—lymph node—thyroid cancer	9.12e-05	0.00653	CbGeAlD
Doxorubicin—ABCC3—thyroid gland—thyroid cancer	8.9e-05	0.00637	CbGeAlD
Doxorubicin—ABCC10—thyroid gland—thyroid cancer	8.85e-05	0.00634	CbGeAlD
Doxorubicin—NQO1—head—thyroid cancer	8.79e-05	0.0063	CbGeAlD
Doxorubicin—ABCG2—saliva-secreting gland—thyroid cancer	8.49e-05	0.00608	CbGeAlD
Doxorubicin—RALBP1—lymph node—thyroid cancer	8.23e-05	0.0059	CbGeAlD
Doxorubicin—NOS3—lymph node—thyroid cancer	8.1e-05	0.0058	CbGeAlD
Doxorubicin—TOP2A—Afatinib—Vandetanib—thyroid cancer	8.09e-05	0.127	CbGdCrCtD
Doxorubicin—ABCC1—trachea—thyroid cancer	7.91e-05	0.00567	CbGeAlD
Doxorubicin—ABCC3—head—thyroid cancer	7.89e-05	0.00565	CbGeAlD
Doxorubicin—CBR1—lymph node—thyroid cancer	7.69e-05	0.0055	CbGeAlD
Doxorubicin—AKR1C3—lymph node—thyroid cancer	7.59e-05	0.00544	CbGeAlD
Doxorubicin—TOP2A—Gefitinib—Vandetanib—thyroid cancer	7.07e-05	0.111	CbGdCrCtD
Doxorubicin—CYP1B1—thyroid gland—thyroid cancer	6.96e-05	0.00498	CbGeAlD
Doxorubicin—POR—lymph node—thyroid cancer	6.93e-05	0.00496	CbGeAlD
Doxorubicin—TOP2A—lymph node—thyroid cancer	6.46e-05	0.00463	CbGeAlD
Doxorubicin—ABCC1—thyroid gland—thyroid cancer	6.26e-05	0.00448	CbGeAlD
Doxorubicin—CYP1B1—head—thyroid cancer	6.18e-05	0.00442	CbGeAlD
Doxorubicin—NQO1—lymph node—thyroid cancer	6.16e-05	0.00441	CbGeAlD
Doxorubicin—ABCC3—lymph node—thyroid cancer	5.53e-05	0.00396	CbGeAlD
Doxorubicin—ABCC10—lymph node—thyroid cancer	5.5e-05	0.00394	CbGeAlD
Doxorubicin—AURKA—Idarubicin—Epirubicin—thyroid cancer	5.5e-05	0.0864	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Epirubicin—thyroid cancer	5.5e-05	0.0864	CbGdCrCtD
Doxorubicin—ABCG2—thyroid gland—thyroid cancer	5.18e-05	0.00371	CbGeAlD
Doxorubicin—ABCC2—lymph node—thyroid cancer	4.42e-05	0.00316	CbGeAlD
Doxorubicin—CYP1B1—lymph node—thyroid cancer	4.32e-05	0.0031	CbGeAlD
Doxorubicin—CYP2B6—head—thyroid cancer	4.24e-05	0.00304	CbGeAlD
Doxorubicin—ABCC1—lymph node—thyroid cancer	3.89e-05	0.00279	CbGeAlD
Doxorubicin—ABCB1—trachea—thyroid cancer	3.23e-05	0.00231	CbGeAlD
Doxorubicin—ABCG2—lymph node—thyroid cancer	3.22e-05	0.00231	CbGeAlD
Doxorubicin—CYP2D6—head—thyroid cancer	3.15e-05	0.00226	CbGeAlD
Doxorubicin—ABCB1—thyroid gland—thyroid cancer	2.56e-05	0.00183	CbGeAlD
Doxorubicin—ABCB1—head—thyroid cancer	2.27e-05	0.00162	CbGeAlD
Doxorubicin—TOP2A—Idarubicin—Epirubicin—thyroid cancer	2.1e-05	0.033	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	2.1e-05	0.033	CbGdCrCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Vaginal inflammation—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Ventricular tachycardia—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Pulmonary embolism—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Hepatocellular injury—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Hiccups—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	1.87e-05	0.00046	CcSEcCtD
Doxorubicin—Injection site reaction—Epirubicin—thyroid cancer	1.86e-05	0.000457	CcSEcCtD
Doxorubicin—Abnormal dreams—Epirubicin—thyroid cancer	1.85e-05	0.000455	CcSEcCtD
Doxorubicin—Dermatitis contact—Epirubicin—thyroid cancer	1.85e-05	0.000455	CcSEcCtD
Doxorubicin—Dry mouth—Sorafenib—thyroid cancer	1.84e-05	0.000453	CcSEcCtD
Doxorubicin—Eructation—Epirubicin—thyroid cancer	1.84e-05	0.000452	CcSEcCtD
Doxorubicin—Hyperkalaemia—Epirubicin—thyroid cancer	1.84e-05	0.000452	CcSEcCtD
Doxorubicin—Diarrhoea—Vandetanib—thyroid cancer	1.83e-05	0.00045	CcSEcCtD
Doxorubicin—Melaena—Epirubicin—thyroid cancer	1.83e-05	0.000449	CcSEcCtD
Doxorubicin—Cystitis noninfective—Epirubicin—thyroid cancer	1.83e-05	0.000449	CcSEcCtD
Doxorubicin—Salivary hypersecretion—Epirubicin—thyroid cancer	1.82e-05	0.000447	CcSEcCtD
Doxorubicin—Influenza like illness—Epirubicin—thyroid cancer	1.82e-05	0.000447	CcSEcCtD
Doxorubicin—Cystitis—Epirubicin—thyroid cancer	1.81e-05	0.000444	CcSEcCtD
Doxorubicin—Anaphylactic shock—Sorafenib—thyroid cancer	1.81e-05	0.000444	CcSEcCtD
Doxorubicin—Colitis—Epirubicin—thyroid cancer	1.8e-05	0.000442	CcSEcCtD
Doxorubicin—Infection—Sorafenib—thyroid cancer	1.8e-05	0.000441	CcSEcCtD
Doxorubicin—Candida infection—Epirubicin—thyroid cancer	1.79e-05	0.000439	CcSEcCtD
Doxorubicin—Skin exfoliation—Epirubicin—thyroid cancer	1.79e-05	0.000439	CcSEcCtD
Doxorubicin—Shock—Sorafenib—thyroid cancer	1.78e-05	0.000437	CcSEcCtD
Doxorubicin—Fluid retention—Epirubicin—thyroid cancer	1.78e-05	0.000437	CcSEcCtD
Doxorubicin—Nervous system disorder—Sorafenib—thyroid cancer	1.77e-05	0.000435	CcSEcCtD
Doxorubicin—Dizziness—Vandetanib—thyroid cancer	1.77e-05	0.000435	CcSEcCtD
Doxorubicin—Thrombocytopenia—Sorafenib—thyroid cancer	1.77e-05	0.000435	CcSEcCtD
Doxorubicin—Blood urea increased—Epirubicin—thyroid cancer	1.77e-05	0.000434	CcSEcCtD
Doxorubicin—Vaginal infection—Epirubicin—thyroid cancer	1.77e-05	0.000434	CcSEcCtD
Doxorubicin—Aplastic anaemia—Epirubicin—thyroid cancer	1.76e-05	0.000432	CcSEcCtD
Doxorubicin—Neuropathy—Epirubicin—thyroid cancer	1.76e-05	0.000432	CcSEcCtD
Doxorubicin—Skin disorder—Sorafenib—thyroid cancer	1.76e-05	0.000431	CcSEcCtD
Doxorubicin—Dry eye—Epirubicin—thyroid cancer	1.73e-05	0.000425	CcSEcCtD
Doxorubicin—Anorexia—Sorafenib—thyroid cancer	1.72e-05	0.000423	CcSEcCtD
Doxorubicin—Cramps of lower extremities—Epirubicin—thyroid cancer	1.72e-05	0.000423	CcSEcCtD
Doxorubicin—Coma—Epirubicin—thyroid cancer	1.71e-05	0.00042	CcSEcCtD
Doxorubicin—Oesophagitis—Epirubicin—thyroid cancer	1.71e-05	0.00042	CcSEcCtD
Doxorubicin—Vomiting—Vandetanib—thyroid cancer	1.7e-05	0.000419	CcSEcCtD
Doxorubicin—Rash maculo-papular—Epirubicin—thyroid cancer	1.7e-05	0.000418	CcSEcCtD
Doxorubicin—Mouth ulceration—Epirubicin—thyroid cancer	1.69e-05	0.000416	CcSEcCtD
Doxorubicin—Neoplasm—Epirubicin—thyroid cancer	1.69e-05	0.000416	CcSEcCtD
Doxorubicin—Bladder pain—Epirubicin—thyroid cancer	1.69e-05	0.000416	CcSEcCtD
Doxorubicin—Ecchymosis—Epirubicin—thyroid cancer	1.69e-05	0.000416	CcSEcCtD
Doxorubicin—Rash—Vandetanib—thyroid cancer	1.69e-05	0.000415	CcSEcCtD
Doxorubicin—Dermatitis—Vandetanib—thyroid cancer	1.69e-05	0.000415	CcSEcCtD
Doxorubicin—Headache—Vandetanib—thyroid cancer	1.68e-05	0.000412	CcSEcCtD
Doxorubicin—Pulmonary oedema—Epirubicin—thyroid cancer	1.67e-05	0.000409	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	1.65e-05	0.000405	CcSEcCtD
Doxorubicin—Hypertonia—Epirubicin—thyroid cancer	1.64e-05	0.000403	CcSEcCtD
Doxorubicin—Abnormal vision—Epirubicin—thyroid cancer	1.63e-05	0.000401	CcSEcCtD
Doxorubicin—Mental disability—Epirubicin—thyroid cancer	1.62e-05	0.000399	CcSEcCtD
Doxorubicin—Sepsis—Epirubicin—thyroid cancer	1.62e-05	0.000399	CcSEcCtD
Doxorubicin—Dyspnoea—Sorafenib—thyroid cancer	1.61e-05	0.000396	CcSEcCtD
Doxorubicin—Lymphadenopathy—Epirubicin—thyroid cancer	1.59e-05	0.000391	CcSEcCtD
Doxorubicin—Nausea—Vandetanib—thyroid cancer	1.59e-05	0.000391	CcSEcCtD
Doxorubicin—Dyspepsia—Sorafenib—thyroid cancer	1.59e-05	0.000391	CcSEcCtD
Doxorubicin—ABCB1—lymph node—thyroid cancer	1.59e-05	0.00114	CbGeAlD
Doxorubicin—Phlebitis—Epirubicin—thyroid cancer	1.58e-05	0.000388	CcSEcCtD
Doxorubicin—Decreased appetite—Sorafenib—thyroid cancer	1.57e-05	0.000386	CcSEcCtD
Doxorubicin—Thrombophlebitis—Epirubicin—thyroid cancer	1.57e-05	0.000386	CcSEcCtD
Doxorubicin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	1.56e-05	0.000384	CcSEcCtD
Doxorubicin—Diabetes mellitus—Epirubicin—thyroid cancer	1.56e-05	0.000384	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Sorafenib—thyroid cancer	1.56e-05	0.000383	CcSEcCtD
Doxorubicin—Fatigue—Sorafenib—thyroid cancer	1.56e-05	0.000383	CcSEcCtD
Doxorubicin—Hepatic function abnormal—Epirubicin—thyroid cancer	1.56e-05	0.000382	CcSEcCtD
Doxorubicin—Photosensitivity—Epirubicin—thyroid cancer	1.55e-05	0.00038	CcSEcCtD
Doxorubicin—Constipation—Sorafenib—thyroid cancer	1.55e-05	0.00038	CcSEcCtD
Doxorubicin—Pain—Sorafenib—thyroid cancer	1.55e-05	0.00038	CcSEcCtD
Doxorubicin—Vascular purpura—Epirubicin—thyroid cancer	1.52e-05	0.000373	CcSEcCtD
Doxorubicin—Eczema—Epirubicin—thyroid cancer	1.51e-05	0.000372	CcSEcCtD
Doxorubicin—Hepatic failure—Epirubicin—thyroid cancer	1.51e-05	0.000372	CcSEcCtD
Doxorubicin—Eye pain—Epirubicin—thyroid cancer	1.51e-05	0.00037	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Epirubicin—thyroid cancer	1.5e-05	0.000368	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Sorafenib—thyroid cancer	1.48e-05	0.000363	CcSEcCtD
Doxorubicin—Renal failure acute—Epirubicin—thyroid cancer	1.47e-05	0.000362	CcSEcCtD
Doxorubicin—Hot flush—Epirubicin—thyroid cancer	1.45e-05	0.000357	CcSEcCtD
Doxorubicin—Increased appetite—Epirubicin—thyroid cancer	1.45e-05	0.000355	CcSEcCtD
Doxorubicin—Dermatitis exfoliative—Epirubicin—thyroid cancer	1.44e-05	0.000354	CcSEcCtD
Doxorubicin—Menopausal symptoms—Epirubicin—thyroid cancer	1.44e-05	0.000354	CcSEcCtD
Doxorubicin—Urticaria—Sorafenib—thyroid cancer	1.44e-05	0.000353	CcSEcCtD
Doxorubicin—Abdominal pain—Sorafenib—thyroid cancer	1.43e-05	0.000351	CcSEcCtD
Doxorubicin—Body temperature increased—Sorafenib—thyroid cancer	1.43e-05	0.000351	CcSEcCtD
Doxorubicin—Renal impairment—Epirubicin—thyroid cancer	1.43e-05	0.000351	CcSEcCtD
Doxorubicin—Dermatitis bullous—Epirubicin—thyroid cancer	1.42e-05	0.000349	CcSEcCtD
Doxorubicin—Purpura—Epirubicin—thyroid cancer	1.41e-05	0.000346	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Epirubicin—thyroid cancer	1.4e-05	0.000345	CcSEcCtD
Doxorubicin—Cardiac failure—Epirubicin—thyroid cancer	1.39e-05	0.000342	CcSEcCtD
Doxorubicin—Hypoglycaemia—Epirubicin—thyroid cancer	1.39e-05	0.000342	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Epirubicin—thyroid cancer	1.39e-05	0.000341	CcSEcCtD
Doxorubicin—Lethargy—Epirubicin—thyroid cancer	1.39e-05	0.000341	CcSEcCtD
Doxorubicin—Hyponatraemia—Epirubicin—thyroid cancer	1.36e-05	0.000335	CcSEcCtD
Doxorubicin—Pain in extremity—Epirubicin—thyroid cancer	1.36e-05	0.000334	CcSEcCtD
Doxorubicin—Osteoarthritis—Epirubicin—thyroid cancer	1.36e-05	0.000334	CcSEcCtD
Doxorubicin—Diplopia—Epirubicin—thyroid cancer	1.36e-05	0.000334	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	1.36e-05	0.000334	CcSEcCtD
Doxorubicin—Migraine—Epirubicin—thyroid cancer	1.34e-05	0.000329	CcSEcCtD
Doxorubicin—Affect lability—Epirubicin—thyroid cancer	1.34e-05	0.000329	CcSEcCtD
Doxorubicin—Hypersensitivity—Sorafenib—thyroid cancer	1.33e-05	0.000327	CcSEcCtD
Doxorubicin—Face oedema—Epirubicin—thyroid cancer	1.31e-05	0.000322	CcSEcCtD
Doxorubicin—Asthenia—Sorafenib—thyroid cancer	1.3e-05	0.000319	CcSEcCtD
Doxorubicin—Cardiac arrest—Epirubicin—thyroid cancer	1.29e-05	0.000318	CcSEcCtD
Doxorubicin—Mood swings—Epirubicin—thyroid cancer	1.29e-05	0.000316	CcSEcCtD
Doxorubicin—Pruritus—Sorafenib—thyroid cancer	1.28e-05	0.000314	CcSEcCtD
Doxorubicin—Ataxia—Epirubicin—thyroid cancer	1.28e-05	0.000314	CcSEcCtD
Doxorubicin—Blood creatinine increased—Epirubicin—thyroid cancer	1.27e-05	0.000313	CcSEcCtD
Doxorubicin—Dehydration—Epirubicin—thyroid cancer	1.26e-05	0.000311	CcSEcCtD
Doxorubicin—Liver function test abnormal—Epirubicin—thyroid cancer	1.25e-05	0.000308	CcSEcCtD
Doxorubicin—Dry skin—Epirubicin—thyroid cancer	1.25e-05	0.000306	CcSEcCtD
Doxorubicin—Abdominal pain upper—Epirubicin—thyroid cancer	1.24e-05	0.000305	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Epirubicin—thyroid cancer	1.24e-05	0.000305	CcSEcCtD
Doxorubicin—Hypokalaemia—Epirubicin—thyroid cancer	1.24e-05	0.000304	CcSEcCtD
Doxorubicin—Diarrhoea—Sorafenib—thyroid cancer	1.24e-05	0.000304	CcSEcCtD
Doxorubicin—Breast disorder—Epirubicin—thyroid cancer	1.23e-05	0.000302	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	1.22e-05	0.000301	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	1.22e-05	0.000301	CcSEcCtD
Doxorubicin—Nasopharyngitis—Epirubicin—thyroid cancer	1.22e-05	0.000299	CcSEcCtD
Doxorubicin—Gastritis—Epirubicin—thyroid cancer	1.2e-05	0.000296	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	1.2e-05	0.000295	CcSEcCtD
Doxorubicin—Muscular weakness—Epirubicin—thyroid cancer	1.2e-05	0.000295	CcSEcCtD
Doxorubicin—Dizziness—Sorafenib—thyroid cancer	1.2e-05	0.000294	CcSEcCtD
Doxorubicin—Abdominal distension—Epirubicin—thyroid cancer	1.18e-05	0.000291	CcSEcCtD
Doxorubicin—Dysphagia—Epirubicin—thyroid cancer	1.17e-05	0.000289	CcSEcCtD
Doxorubicin—Influenza—Epirubicin—thyroid cancer	1.17e-05	0.000289	CcSEcCtD
Doxorubicin—Asthma—Epirubicin—thyroid cancer	1.17e-05	0.000289	CcSEcCtD
Doxorubicin—Eosinophilia—Epirubicin—thyroid cancer	1.16e-05	0.000286	CcSEcCtD
Doxorubicin—Pancreatitis—Epirubicin—thyroid cancer	1.15e-05	0.000283	CcSEcCtD
Doxorubicin—Vomiting—Sorafenib—thyroid cancer	1.15e-05	0.000282	CcSEcCtD
Doxorubicin—Angina pectoris—Epirubicin—thyroid cancer	1.14e-05	0.000281	CcSEcCtD
Doxorubicin—Rash—Sorafenib—thyroid cancer	1.14e-05	0.00028	CcSEcCtD
Doxorubicin—Dermatitis—Sorafenib—thyroid cancer	1.14e-05	0.00028	CcSEcCtD
Doxorubicin—Headache—Sorafenib—thyroid cancer	1.13e-05	0.000278	CcSEcCtD
Doxorubicin—Bronchitis—Epirubicin—thyroid cancer	1.13e-05	0.000278	CcSEcCtD
Doxorubicin—Pancytopenia—Epirubicin—thyroid cancer	1.12e-05	0.000274	CcSEcCtD
Doxorubicin—Dysuria—Epirubicin—thyroid cancer	1.1e-05	0.00027	CcSEcCtD
Doxorubicin—Neutropenia—Epirubicin—thyroid cancer	1.1e-05	0.00027	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Epirubicin—thyroid cancer	1.09e-05	0.000268	CcSEcCtD
Doxorubicin—Pollakiuria—Epirubicin—thyroid cancer	1.09e-05	0.000267	CcSEcCtD
Doxorubicin—Nausea—Sorafenib—thyroid cancer	1.07e-05	0.000264	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Epirubicin—thyroid cancer	1.07e-05	0.000263	CcSEcCtD
Doxorubicin—Weight increased—Epirubicin—thyroid cancer	1.07e-05	0.000263	CcSEcCtD
Doxorubicin—Weight decreased—Epirubicin—thyroid cancer	1.06e-05	0.000261	CcSEcCtD
Doxorubicin—Hyperglycaemia—Epirubicin—thyroid cancer	1.06e-05	0.00026	CcSEcCtD
Doxorubicin—Pneumonia—Epirubicin—thyroid cancer	1.05e-05	0.000259	CcSEcCtD
Doxorubicin—Infestation—Epirubicin—thyroid cancer	1.05e-05	0.000257	CcSEcCtD
Doxorubicin—Infestation NOS—Epirubicin—thyroid cancer	1.05e-05	0.000257	CcSEcCtD
Doxorubicin—Drowsiness—Epirubicin—thyroid cancer	1.05e-05	0.000257	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	1.04e-05	0.000255	CcSEcCtD
Doxorubicin—Renal failure—Epirubicin—thyroid cancer	1.03e-05	0.000253	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Epirubicin—thyroid cancer	1.03e-05	0.000252	CcSEcCtD
Doxorubicin—Stomatitis—Epirubicin—thyroid cancer	1.02e-05	0.000251	CcSEcCtD
Doxorubicin—Jaundice—Epirubicin—thyroid cancer	1.02e-05	0.000251	CcSEcCtD
Doxorubicin—Urinary tract infection—Epirubicin—thyroid cancer	1.02e-05	0.00025	CcSEcCtD
Doxorubicin—Conjunctivitis—Epirubicin—thyroid cancer	1.02e-05	0.00025	CcSEcCtD
Doxorubicin—Sweating—Epirubicin—thyroid cancer	1e-05	0.000247	CcSEcCtD
Doxorubicin—Haematuria—Epirubicin—thyroid cancer	9.99e-06	0.000245	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Epirubicin—thyroid cancer	9.91e-06	0.000243	CcSEcCtD
Doxorubicin—Epistaxis—Epirubicin—thyroid cancer	9.88e-06	0.000243	CcSEcCtD
Doxorubicin—Sinusitis—Epirubicin—thyroid cancer	9.83e-06	0.000241	CcSEcCtD
Doxorubicin—Agranulocytosis—Epirubicin—thyroid cancer	9.77e-06	0.00024	CcSEcCtD
Doxorubicin—Bradycardia—Epirubicin—thyroid cancer	9.57e-06	0.000235	CcSEcCtD
Doxorubicin—Haemoglobin—Epirubicin—thyroid cancer	9.45e-06	0.000232	CcSEcCtD
Doxorubicin—Rhinitis—Epirubicin—thyroid cancer	9.43e-06	0.000232	CcSEcCtD
Doxorubicin—Haemorrhage—Epirubicin—thyroid cancer	9.4e-06	0.000231	CcSEcCtD
Doxorubicin—Hepatitis—Epirubicin—thyroid cancer	9.4e-06	0.000231	CcSEcCtD
Doxorubicin—Hypoaesthesia—Epirubicin—thyroid cancer	9.36e-06	0.00023	CcSEcCtD
Doxorubicin—Pharyngitis—Epirubicin—thyroid cancer	9.33e-06	0.000229	CcSEcCtD
Doxorubicin—Urinary tract disorder—Epirubicin—thyroid cancer	9.29e-06	0.000228	CcSEcCtD
Doxorubicin—Oedema peripheral—Epirubicin—thyroid cancer	9.26e-06	0.000228	CcSEcCtD
Doxorubicin—Connective tissue disorder—Epirubicin—thyroid cancer	9.24e-06	0.000227	CcSEcCtD
Doxorubicin—Urethral disorder—Epirubicin—thyroid cancer	9.22e-06	0.000226	CcSEcCtD
Doxorubicin—Visual impairment—Epirubicin—thyroid cancer	9.06e-06	0.000223	CcSEcCtD
Doxorubicin—Erythema multiforme—Epirubicin—thyroid cancer	8.89e-06	0.000218	CcSEcCtD
Doxorubicin—Eye disorder—Epirubicin—thyroid cancer	8.79e-06	0.000216	CcSEcCtD
Doxorubicin—Tinnitus—Epirubicin—thyroid cancer	8.77e-06	0.000215	CcSEcCtD
Doxorubicin—Flushing—Epirubicin—thyroid cancer	8.73e-06	0.000214	CcSEcCtD
Doxorubicin—Cardiac disorder—Epirubicin—thyroid cancer	8.73e-06	0.000214	CcSEcCtD
Doxorubicin—Angiopathy—Epirubicin—thyroid cancer	8.53e-06	0.00021	CcSEcCtD
Doxorubicin—Immune system disorder—Epirubicin—thyroid cancer	8.49e-06	0.000209	CcSEcCtD
Doxorubicin—Mediastinal disorder—Epirubicin—thyroid cancer	8.47e-06	0.000208	CcSEcCtD
Doxorubicin—Chills—Epirubicin—thyroid cancer	8.44e-06	0.000207	CcSEcCtD
Doxorubicin—Arrhythmia—Epirubicin—thyroid cancer	8.4e-06	0.000206	CcSEcCtD
Doxorubicin—Alopecia—Epirubicin—thyroid cancer	8.31e-06	0.000204	CcSEcCtD
Doxorubicin—Mental disorder—Epirubicin—thyroid cancer	8.24e-06	0.000202	CcSEcCtD
Doxorubicin—Erythema—Epirubicin—thyroid cancer	8.19e-06	0.000201	CcSEcCtD
Doxorubicin—Malnutrition—Epirubicin—thyroid cancer	8.19e-06	0.000201	CcSEcCtD
Doxorubicin—Flatulence—Epirubicin—thyroid cancer	8.07e-06	0.000198	CcSEcCtD
Doxorubicin—Tension—Epirubicin—thyroid cancer	8.03e-06	0.000197	CcSEcCtD
Doxorubicin—Dysgeusia—Epirubicin—thyroid cancer	8.02e-06	0.000197	CcSEcCtD
Doxorubicin—Nervousness—Epirubicin—thyroid cancer	7.95e-06	0.000195	CcSEcCtD
Doxorubicin—Back pain—Epirubicin—thyroid cancer	7.92e-06	0.000195	CcSEcCtD
Doxorubicin—Muscle spasms—Epirubicin—thyroid cancer	7.87e-06	0.000193	CcSEcCtD
Doxorubicin—Vision blurred—Epirubicin—thyroid cancer	7.71e-06	0.00019	CcSEcCtD
Doxorubicin—Ill-defined disorder—Epirubicin—thyroid cancer	7.59e-06	0.000187	CcSEcCtD
Doxorubicin—Anaemia—Epirubicin—thyroid cancer	7.57e-06	0.000186	CcSEcCtD
Doxorubicin—Agitation—Epirubicin—thyroid cancer	7.52e-06	0.000185	CcSEcCtD
Doxorubicin—Malaise—Epirubicin—thyroid cancer	7.38e-06	0.000181	CcSEcCtD
Doxorubicin—Vertigo—Epirubicin—thyroid cancer	7.35e-06	0.000181	CcSEcCtD
Doxorubicin—Syncope—Epirubicin—thyroid cancer	7.34e-06	0.00018	CcSEcCtD
Doxorubicin—Leukopenia—Epirubicin—thyroid cancer	7.33e-06	0.00018	CcSEcCtD
Doxorubicin—Palpitations—Epirubicin—thyroid cancer	7.23e-06	0.000178	CcSEcCtD
Doxorubicin—Loss of consciousness—Epirubicin—thyroid cancer	7.19e-06	0.000177	CcSEcCtD
Doxorubicin—Cough—Epirubicin—thyroid cancer	7.14e-06	0.000175	CcSEcCtD
Doxorubicin—Convulsion—Epirubicin—thyroid cancer	7.09e-06	0.000174	CcSEcCtD
Doxorubicin—Hypertension—Epirubicin—thyroid cancer	7.07e-06	0.000174	CcSEcCtD
Doxorubicin—Arthralgia—Epirubicin—thyroid cancer	6.97e-06	0.000171	CcSEcCtD
Doxorubicin—Chest pain—Epirubicin—thyroid cancer	6.97e-06	0.000171	CcSEcCtD
Doxorubicin—Myalgia—Epirubicin—thyroid cancer	6.97e-06	0.000171	CcSEcCtD
Doxorubicin—Anxiety—Epirubicin—thyroid cancer	6.94e-06	0.000171	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	6.92e-06	0.00017	CcSEcCtD
Doxorubicin—Discomfort—Epirubicin—thyroid cancer	6.89e-06	0.000169	CcSEcCtD
Doxorubicin—Dry mouth—Epirubicin—thyroid cancer	6.82e-06	0.000167	CcSEcCtD
Doxorubicin—Confusional state—Epirubicin—thyroid cancer	6.74e-06	0.000165	CcSEcCtD
Doxorubicin—Anaphylactic shock—Epirubicin—thyroid cancer	6.68e-06	0.000164	CcSEcCtD
Doxorubicin—Oedema—Epirubicin—thyroid cancer	6.68e-06	0.000164	CcSEcCtD
Doxorubicin—Infection—Epirubicin—thyroid cancer	6.64e-06	0.000163	CcSEcCtD
Doxorubicin—Shock—Epirubicin—thyroid cancer	6.57e-06	0.000161	CcSEcCtD
Doxorubicin—Nervous system disorder—Epirubicin—thyroid cancer	6.55e-06	0.000161	CcSEcCtD
Doxorubicin—Thrombocytopenia—Epirubicin—thyroid cancer	6.54e-06	0.000161	CcSEcCtD
Doxorubicin—Tachycardia—Epirubicin—thyroid cancer	6.52e-06	0.00016	CcSEcCtD
Doxorubicin—Skin disorder—Epirubicin—thyroid cancer	6.49e-06	0.000159	CcSEcCtD
Doxorubicin—Hyperhidrosis—Epirubicin—thyroid cancer	6.46e-06	0.000159	CcSEcCtD
Doxorubicin—Anorexia—Epirubicin—thyroid cancer	6.37e-06	0.000156	CcSEcCtD
Doxorubicin—Hypotension—Epirubicin—thyroid cancer	6.24e-06	0.000153	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	6.09e-06	0.00015	CcSEcCtD
Doxorubicin—Insomnia—Epirubicin—thyroid cancer	6.04e-06	0.000148	CcSEcCtD
Doxorubicin—Paraesthesia—Epirubicin—thyroid cancer	6e-06	0.000147	CcSEcCtD
Doxorubicin—Dyspnoea—Epirubicin—thyroid cancer	5.96e-06	0.000146	CcSEcCtD
Doxorubicin—Somnolence—Epirubicin—thyroid cancer	5.94e-06	0.000146	CcSEcCtD
Doxorubicin—Dyspepsia—Epirubicin—thyroid cancer	5.88e-06	0.000144	CcSEcCtD
Doxorubicin—Decreased appetite—Epirubicin—thyroid cancer	5.81e-06	0.000143	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Epirubicin—thyroid cancer	5.77e-06	0.000142	CcSEcCtD
Doxorubicin—Fatigue—Epirubicin—thyroid cancer	5.76e-06	0.000141	CcSEcCtD
Doxorubicin—Pain—Epirubicin—thyroid cancer	5.71e-06	0.00014	CcSEcCtD
Doxorubicin—Constipation—Epirubicin—thyroid cancer	5.71e-06	0.00014	CcSEcCtD
Doxorubicin—Feeling abnormal—Epirubicin—thyroid cancer	5.5e-06	0.000135	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Epirubicin—thyroid cancer	5.46e-06	0.000134	CcSEcCtD
Doxorubicin—Urticaria—Epirubicin—thyroid cancer	5.31e-06	0.00013	CcSEcCtD
Doxorubicin—Body temperature increased—Epirubicin—thyroid cancer	5.28e-06	0.00013	CcSEcCtD
Doxorubicin—Abdominal pain—Epirubicin—thyroid cancer	5.28e-06	0.00013	CcSEcCtD
Doxorubicin—Hypersensitivity—Epirubicin—thyroid cancer	4.92e-06	0.000121	CcSEcCtD
Doxorubicin—Asthenia—Epirubicin—thyroid cancer	4.79e-06	0.000118	CcSEcCtD
Doxorubicin—Pruritus—Epirubicin—thyroid cancer	4.73e-06	0.000116	CcSEcCtD
Doxorubicin—Diarrhoea—Epirubicin—thyroid cancer	4.57e-06	0.000112	CcSEcCtD
Doxorubicin—Dizziness—Epirubicin—thyroid cancer	4.42e-06	0.000109	CcSEcCtD
Doxorubicin—Vomiting—Epirubicin—thyroid cancer	4.25e-06	0.000104	CcSEcCtD
Doxorubicin—Rash—Epirubicin—thyroid cancer	4.21e-06	0.000103	CcSEcCtD
Doxorubicin—Dermatitis—Epirubicin—thyroid cancer	4.21e-06	0.000103	CcSEcCtD
Doxorubicin—Headache—Epirubicin—thyroid cancer	4.18e-06	0.000103	CcSEcCtD
Doxorubicin—Nausea—Epirubicin—thyroid cancer	3.97e-06	9.75e-05	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—MEN1—thyroid cancer	3.95e-06	0.000191	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MINPP1—thyroid cancer	3.93e-06	0.00019	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—thyroid cancer	3.93e-06	0.00019	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TPR—thyroid cancer	3.9e-06	0.000189	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—NRAS—thyroid cancer	3.87e-06	0.000188	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—RXRA—thyroid cancer	3.87e-06	0.000187	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SST—thyroid cancer	3.86e-06	0.000187	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRG1—thyroid cancer	3.86e-06	0.000187	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTEN—thyroid cancer	3.85e-06	0.000187	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTEN—thyroid cancer	3.85e-06	0.000187	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PRKAR1A—thyroid cancer	3.84e-06	0.000186	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TERT—thyroid cancer	3.77e-06	0.000182	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—thyroid cancer	3.76e-06	0.000182	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC5A5—thyroid cancer	3.76e-06	0.000182	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—RXRA—thyroid cancer	3.74e-06	0.000181	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.73e-06	0.000181	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CALCA—thyroid cancer	3.72e-06	0.00018	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.7e-06	0.000179	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TPR—thyroid cancer	3.65e-06	0.000177	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.63e-06	0.000176	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.63e-06	0.000176	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTEN—thyroid cancer	3.62e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.61e-06	0.000175	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—thyroid cancer	3.61e-06	0.000175	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HIF1A—thyroid cancer	3.6e-06	0.000174	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRKAR1A—thyroid cancer	3.59e-06	0.000174	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTCH1—thyroid cancer	3.57e-06	0.000173	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—thyroid cancer	3.53e-06	0.000171	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.48e-06	0.000168	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—RXRA—thyroid cancer	3.47e-06	0.000168	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—BRAF—thyroid cancer	3.47e-06	0.000168	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TERT—thyroid cancer	3.46e-06	0.000168	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HPGD—thyroid cancer	3.43e-06	0.000166	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MEN1—thyroid cancer	3.43e-06	0.000166	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDK1—thyroid cancer	3.37e-06	0.000163	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.34e-06	0.000162	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—KRAS—thyroid cancer	3.33e-06	0.000161	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—AKT1—thyroid cancer	3.32e-06	0.000161	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HIF1A—thyroid cancer	3.31e-06	0.00016	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.3e-06	0.00016	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—thyroid cancer	3.29e-06	0.000159	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SST—thyroid cancer	3.26e-06	0.000158	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRG1—thyroid cancer	3.26e-06	0.000158	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	3.25e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—thyroid cancer	3.2e-06	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—RXRA—thyroid cancer	3.16e-06	0.000153	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.15e-06	0.000152	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CHST14—thyroid cancer	3.14e-06	0.000152	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALCA—thyroid cancer	3.14e-06	0.000152	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.11e-06	0.00015	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.11e-06	0.00015	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTEN—thyroid cancer	3.08e-06	0.000149	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TPR—thyroid cancer	3.06e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.06e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC5A5—thyroid cancer	3.05e-06	0.000148	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NRAS—thyroid cancer	3.01e-06	0.000146	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.01e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS2—Disease—BRAF—thyroid cancer	2.98e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—thyroid cancer	2.96e-06	0.000143	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CHST14—thyroid cancer	2.96e-06	0.000143	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TPR—thyroid cancer	2.96e-06	0.000143	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TERT—thyroid cancer	2.93e-06	0.000142	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC5A5—thyroid cancer	2.92e-06	0.000141	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PRKAR1A—thyroid cancer	2.91e-06	0.000141	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—thyroid cancer	2.9e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.87e-06	0.000139	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTEN—thyroid cancer	2.87e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.86e-06	0.000138	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDK1—thyroid cancer	2.84e-06	0.000138	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—thyroid cancer	2.83e-06	0.000137	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HIF1A—thyroid cancer	2.8e-06	0.000135	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTEN—thyroid cancer	2.79e-06	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—BRAF—thyroid cancer	2.74e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.74e-06	0.000133	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—thyroid cancer	2.73e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALCA—thyroid cancer	2.73e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.73e-06	0.000132	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRG1—thyroid cancer	2.7e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TPR—thyroid cancer	2.69e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	2.65e-06	0.000128	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.64e-06	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KRAS—thyroid cancer	2.59e-06	0.000125	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—RXRA—thyroid cancer	2.56e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HPGD—thyroid cancer	2.53e-06	0.000123	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—thyroid cancer	2.53e-06	0.000122	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—AKT1—thyroid cancer	2.5e-06	0.000121	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.49e-06	0.000121	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NRAS—thyroid cancer	2.49e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDK1—thyroid cancer	2.47e-06	0.00012	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—RXRA—thyroid cancer	2.45e-06	0.000119	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARG—thyroid cancer	2.44e-06	0.000118	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.44e-06	0.000118	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTEN—thyroid cancer	2.44e-06	0.000118	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TERT—thyroid cancer	2.43e-06	0.000117	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.42e-06	0.000117	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—thyroid cancer	2.41e-06	0.000117	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.39e-06	0.000116	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HPGD—thyroid cancer	2.39e-06	0.000116	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARG—thyroid cancer	2.36e-06	0.000114	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.33e-06	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HIF1A—thyroid cancer	2.32e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Disease—BRAF—thyroid cancer	2.32e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—thyroid cancer	2.3e-06	0.000111	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.29e-06	0.000111	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRG1—thyroid cancer	2.28e-06	0.00011	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AKT1—thyroid cancer	2.22e-06	0.000107	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AKT1—thyroid cancer	2.22e-06	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—thyroid cancer	2.22e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC5A5—thyroid cancer	2.21e-06	0.000107	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.21e-06	0.000107	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—thyroid cancer	2.2e-06	0.000107	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARG—thyroid cancer	2.19e-06	0.000106	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—thyroid cancer	2.18e-06	0.000105	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.15e-06	0.000104	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KRAS—thyroid cancer	2.14e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.13e-06	0.000103	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTEN—thyroid cancer	2.1e-06	0.000102	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—thyroid cancer	2.09e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.07e-06	0.0001	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.06e-06	9.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TERT—thyroid cancer	2.05e-06	9.92e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.01e-06	9.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—thyroid cancer	1.99e-06	9.65e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRG1—thyroid cancer	1.99e-06	9.61e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TPR—thyroid cancer	1.97e-06	9.55e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HIF1A—thyroid cancer	1.96e-06	9.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.95e-06	9.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—thyroid cancer	1.94e-06	9.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.94e-06	9.39e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CHST14—thyroid cancer	1.94e-06	9.37e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—thyroid cancer	1.93e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—RXRA—thyroid cancer	1.92e-06	9.31e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—thyroid cancer	1.92e-06	9.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BRAF—thyroid cancer	1.92e-06	9.3e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—thyroid cancer	1.91e-06	9.26e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—thyroid cancer	1.88e-06	9.08e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—thyroid cancer	1.87e-06	9.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—thyroid cancer	1.87e-06	9.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.87e-06	9.06e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—RXRA—thyroid cancer	1.86e-06	9.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—thyroid cancer	1.86e-06	8.98e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—thyroid cancer	1.82e-06	8.81e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.81e-06	8.76e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TERT—thyroid cancer	1.78e-06	8.63e-05	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—thyroid cancer	1.78e-06	8.59e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—thyroid cancer	1.72e-06	8.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—thyroid cancer	1.72e-06	8.34e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HIF1A—thyroid cancer	1.71e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—RXRA—thyroid cancer	1.69e-06	8.19e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—thyroid cancer	1.68e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—thyroid cancer	1.67e-06	8.07e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—thyroid cancer	1.66e-06	8.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.64e-06	7.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—thyroid cancer	1.63e-06	7.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BRAF—thyroid cancer	1.62e-06	7.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—thyroid cancer	1.62e-06	7.83e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—thyroid cancer	1.62e-06	7.83e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—thyroid cancer	1.61e-06	7.82e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—thyroid cancer	1.61e-06	7.78e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—thyroid cancer	1.59e-06	7.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—thyroid cancer	1.57e-06	7.59e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HPGD—thyroid cancer	1.56e-06	7.55e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—thyroid cancer	1.55e-06	7.5e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—thyroid cancer	1.5e-06	7.28e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—thyroid cancer	1.48e-06	7.18e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.48e-06	7.15e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—thyroid cancer	1.46e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TPR—thyroid cancer	1.45e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.45e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.43e-06	6.93e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BRAF—thyroid cancer	1.41e-06	6.84e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—thyroid cancer	1.41e-06	6.81e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—thyroid cancer	1.4e-06	6.79e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—thyroid cancer	1.37e-06	6.64e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TPR—thyroid cancer	1.37e-06	6.64e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—thyroid cancer	1.37e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—thyroid cancer	1.35e-06	6.55e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.35e-06	6.53e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—thyroid cancer	1.27e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—thyroid cancer	1.26e-06	6.1e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—thyroid cancer	1.25e-06	6.07e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—RXRA—thyroid cancer	1.24e-06	6.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.23e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—thyroid cancer	1.22e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—thyroid cancer	1.21e-06	5.88e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—thyroid cancer	1.21e-06	5.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—thyroid cancer	1.21e-06	5.84e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—thyroid cancer	1.18e-06	5.73e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—thyroid cancer	1.17e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—thyroid cancer	1.14e-06	5.53e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—thyroid cancer	1.14e-06	5.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—thyroid cancer	1.11e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—thyroid cancer	1.11e-06	5.37e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.09e-06	5.27e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—thyroid cancer	1.07e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—thyroid cancer	1.07e-06	5.16e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—thyroid cancer	1.06e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—thyroid cancer	1.04e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.03e-06	4.97e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—thyroid cancer	1.02e-06	4.94e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—thyroid cancer	9.95e-07	4.82e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—thyroid cancer	9.67e-07	4.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—thyroid cancer	9.55e-07	4.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—thyroid cancer	9.41e-07	4.55e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—thyroid cancer	9.33e-07	4.51e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—thyroid cancer	9.24e-07	4.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—thyroid cancer	9.23e-07	4.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—RXRA—thyroid cancer	9.15e-07	4.43e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TPR—thyroid cancer	8.96e-07	4.34e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—thyroid cancer	8.88e-07	4.3e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—thyroid cancer	8.83e-07	4.27e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.82e-07	4.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—thyroid cancer	8.78e-07	4.25e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—thyroid cancer	8.67e-07	4.2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—RXRA—thyroid cancer	8.62e-07	4.17e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—thyroid cancer	8.41e-07	4.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—thyroid cancer	8.33e-07	4.03e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—thyroid cancer	8.06e-07	3.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—thyroid cancer	7.88e-07	3.81e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—thyroid cancer	7.83e-07	3.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—thyroid cancer	7.8e-07	3.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—thyroid cancer	7.8e-07	3.77e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—thyroid cancer	7.64e-07	3.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—thyroid cancer	7.46e-07	3.61e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—thyroid cancer	7.33e-07	3.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.71e-07	3.25e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—thyroid cancer	6.59e-07	3.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—thyroid cancer	6.49e-07	3.14e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—thyroid cancer	6.39e-07	3.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—thyroid cancer	6.16e-07	2.98e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—thyroid cancer	6.13e-07	2.97e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—thyroid cancer	5.78e-07	2.8e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—thyroid cancer	5.73e-07	2.78e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—RXRA—thyroid cancer	5.64e-07	2.73e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—thyroid cancer	5.44e-07	2.64e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—thyroid cancer	5.37e-07	2.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—thyroid cancer	4.8e-07	2.32e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—thyroid cancer	4.64e-07	2.25e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—thyroid cancer	4.54e-07	2.2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.28e-07	2.07e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—thyroid cancer	4.22e-07	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—thyroid cancer	3.96e-07	1.92e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—thyroid cancer	3.73e-07	1.81e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—thyroid cancer	3.56e-07	1.72e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—thyroid cancer	3.1e-07	1.5e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.8e-07	1.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—thyroid cancer	2.44e-07	1.18e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—thyroid cancer	2.28e-07	1.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—thyroid cancer	2.15e-07	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.41e-07	6.81e-06	CbGpPWpGaD
